Items tagged with Treatment

TB activists for first time challenge TB drug patent in India (post with simple image)

TB activists for first time challenge TB drug patent in India, in bid to prevent Johnson & Johnson from extending monopoly.

TB CAB statement on safety of using bedaquiline and delamanid together (post with simple image)

Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake.

TAG statement on FDA priority review of pretomanid (post with simple image)

Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.

MSF: Johnson & Johnson should make TB drug available for all at $1/day (post with simple image)

MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.

Ad-hoc donations of bedaquiline threaten sustainable, affordable access for patients (post with simple image)

Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.

FDA Antimicrobial Drugs Advisory Committee recommends approval of pretomanid (post with simple image)

Investigational drug pretomanid is under regulatory review by FDA for treatment of XDR-TB and treatment-intolerant or non-responsive MDR-TB as part of a new investigational regimen.

Activists demand Johnson & Johnson drop the price of bedaquiline (post with simple image)

Activists storm the corporate stall of Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) at the 9th South African AIDS Conference.

Page 73 of 73 · Total posts: 0

←First 72 73